Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

Relationship between telmisartan dose and glycaemic control in Japanese patients with type 2 diabetes mellitus and hypertension: a retrospective study.

Hamamoto Y, Honjo S, Kawasaki Y, Ikeda H, Mori K, Fujimoto K, Tatsuoka H, Iwasaki Y, Nomura K, Wada Y, Koshiyama H.

Clin Drug Investig. 2012 Sep 1;32(9):577-82. doi: 10.2165/11633890-000000000-00000.

PMID:
22812514
[PubMed - indexed for MEDLINE]
2.

Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone.

Derosa G, Fogari E, D'Angelo A, Cicero AF, Salvadeo SA, Ragonesi PD, Ferrari I, Gravina A, Fassi R, Fogari R.

J Clin Pharm Ther. 2007 Jun;32(3):261-8.

PMID:
17489878
[PubMed - indexed for MEDLINE]
3.

Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patients.

Mori H, Okada Y, Arao T, Nishida K, Tanaka Y.

Adv Ther. 2012 Jul;29(7):635-44. doi: 10.1007/s12325-012-0032-x. Epub 2012 Jul 20.

PMID:
22821644
[PubMed - indexed for MEDLINE]
4.
5.

Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus.

Ozaki N, Nomura Y, Sobajima H, Kondo K, Oiso Y.

Eur J Intern Med. 2010 Jun;21(3):236-9. doi: 10.1016/j.ejim.2010.01.014. Epub 2010 Feb 18.

PMID:
20493430
[PubMed - indexed for MEDLINE]
6.

Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients.

Watanabe M, Inukai K, Sumita T, Ikebukuro K, Ito D, Kurihara S, Ono H, Awata T, Katayama S.

Intern Med. 2010;49(17):1843-7. Epub 2010 Sep 1.

PMID:
20823643
[PubMed - indexed for MEDLINE]
Free Article
7.

Antihypertensive and metabolic effects of high-dose olmesartan and telmisartan in type 2 diabetes patients with hypertension.

Arao T, Okada Y, Mori H, Nishida K, Tanaka Y.

Endocr J. 2013;60(5):563-70. Epub 2013 Jan 10.

PMID:
23303198
[PubMed - indexed for MEDLINE]
Free Article
8.

Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.

Rizos CV, Milionis HJ, Kostapanos MS, Florentin M, Kostara CE, Elisaf MS, Liberopoulos EN.

Clin Ther. 2010 Mar;32(3):492-505. doi: 10.1016/j.clinthera.2010.03.018.

PMID:
20399986
[PubMed - indexed for MEDLINE]
9.

Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.

Derosa G, Cicero AF, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Ferrari I, Gravina A, Fogari R.

Hypertens Res. 2006 Nov;29(11):849-56.

PMID:
17345784
[PubMed - indexed for MEDLINE]
10.

The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients.

Negro R, Hassan H.

J Renin Angiotensin Aldosterone Syst. 2006 Dec;7(4):243-6.

PMID:
17318795
[PubMed - indexed for MEDLINE]
11.

Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan.

Wago T, Yoshimoto T, Akaza I, Tsuchiya K, Izumiyama H, Doi M, Hirata Y.

Hypertens Res. 2010 Aug;33(8):796-801. doi: 10.1038/hr.2010.107. Epub 2010 Jun 17.

PMID:
20555330
[PubMed - indexed for MEDLINE]
13.

Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.

Galle J, Schwedhelm E, Pinnetti S, Böger RH, Wanner C; VIVALDI investigators.

Nephrol Dial Transplant. 2008 Oct;23(10):3174-83. doi: 10.1093/ndt/gfn230. Epub 2008 May 1.

PMID:
18450829
[PubMed - indexed for MEDLINE]
Free Article
14.

The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control.

Yamana A, Arita M, Furuta M, Shimajiri Y, Sanke T.

Diabetes Res Clin Pract. 2008 Oct;82(1):127-31. doi: 10.1016/j.diabres.2008.07.003. Epub 2008 Aug 9.

PMID:
18692932
[PubMed - indexed for MEDLINE]
15.

[The clinical and hemodynamic efficacy of telmisartan and enalapril in the treatment of arterial hypertension in patients with type 2 diabetes mellitus].

Tatarchenko IP, Pozdniakova NV, Mordovina AG, Morozova OI, Zaĭtseva AV.

Ter Arkh. 2009;81(12):11-5. Russian.

PMID:
20481040
[PubMed - indexed for MEDLINE]
16.

Alterations of insulin resistance and the serum adiponectin level in patients with type 2 diabetes mellitus under the usual antihypertensive dosage of telmisartan treatment.

Fuke Y, Fujita T, Satomura A, Wada Y, Matsumoto K.

Diabetes Technol Ther. 2010 May;12(5):393-8. doi: 10.1089/dia.2009.0126.

PMID:
20388049
[PubMed - indexed for MEDLINE]
17.

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.

Derosa G, Cicero AF, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Fassi R, Fogari R.

Clin Ther. 2007 Apr;29(4):602-10.

PMID:
17617283
[PubMed - indexed for MEDLINE]
18.

Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome.

Ichikawa Y.

Intern Med. 2007;46(17):1331-6. Epub 2007 Sep 3.

PMID:
17827829
[PubMed - indexed for MEDLINE]
Free Article
19.

Telmisartan but not candesartan affects adiponectin expression in vivo and in vitro.

Yamada S, Ano N, Toda K, Kitaoka A, Shiono K, Inoue G, Atsuda K, Irie J.

Hypertens Res. 2008 Apr;31(4):601-6. doi: 10.1291/hypres.31.601.

PMID:
18633170
[PubMed - indexed for MEDLINE]
20.

Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies.

Aranda P, Segura J, Ruilope LM, Aranda FJ, Frutos MA, López V, López de Novales E.

Am J Kidney Dis. 2005 Dec;46(6):1074-9.

PMID:
16310573
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk